Tarran Jones
6Patents
5h-index
8Co-inventors
52Inventor score
Filing activity: Dec 8, 2004 → Jun 28, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8246958B2 | Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies | Physics | 53 | Active |
| US7829086B2 | Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease | Chemistry; Metallurgy | 36 | Active |
| US7435802B2 | Humanized anti-VLA4 immunoglobulins | Physics | 11 | Expired |
| US8664363B2 | Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease | Chemistry; Metallurgy | 9 | Active |
| US8389688B2 | Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease | Chemistry; Metallurgy | 7 | Active |
| US11530257B2 | Chimeric antibodies for treatment of amyloid deposition diseases | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.